These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 15839614)

  • 61. Clinical performance of the Food and Drug Administration-Approved high-risk HPV test for the detection of high-grade cervicovaginal lesions.
    Zhou H; Mody RR; Luna E; Armylagos D; Xu J; Schwartz MR; Mody DR; Ge Y
    Cancer Cytopathol; 2016 May; 124(5):317-23. PubMed ID: 26774025
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Screening properties of human papillomavirus testing for predicting cervical intraepithelial neoplasia in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion smears: a prospective study.
    Dane C; Batmaz G; Dane B; Cetin A
    Ann Diagn Pathol; 2009 Apr; 13(2):73-7. PubMed ID: 19302953
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Histologic Outcomes in HPV-Positive and Cervical Cytology- Negative Women - Screening Results in Northern Thailand.
    Vijakururote L; Suprasert P; Srisomboon J; Siriaunkgul S; Settakorn J; Rewsuwan S
    Asian Pac J Cancer Prev; 2015; 16(16):7271-5. PubMed ID: 26514523
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study.
    Dalstein V; Riethmuller D; Prétet JL; Le Bail Carval K; Sautière JL; Carbillet JP; Kantelip B; Schaal JP; Mougin C
    Int J Cancer; 2003 Sep; 106(3):396-403. PubMed ID: 12845680
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?
    Bhatla N; Dar L; Patro AR; Kumar P; Kriplani A; Gulati A; Iyer VK; Mathur SR; Sreenivas V; Shah KV; Gravitt PE
    Cancer Epidemiol; 2009 Dec; 33(6):446-50. PubMed ID: 19931499
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Use of human papillomavirus testing in the management of atypical glandular cells.
    Schnatz PF; Sharpless KE; O'Sullivan DM
    J Low Genit Tract Dis; 2009 Apr; 13(2):94-101. PubMed ID: 19387129
    [TBL] [Abstract][Full Text] [Related]  

  • 67. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.
    Wright TC; Denny L; Kuhn L; Pollack A; Lorincz A
    JAMA; 2000 Jan; 283(1):81-6. PubMed ID: 10632284
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cervical cytology with a diagnosis of atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion (ASC-H): a follow-up study with corresponding histology and significance of predicting dysplasia by human papillomavirus (HPV) DNA testing.
    Gilani SM; Tashjian R; Fathallah L
    Arch Gynecol Obstet; 2014 Mar; 289(3):645-8. PubMed ID: 24002355
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Linear array genotyping and hybrid capture II assay in detecting human papillomavirus genotypes in women referred for colposcopy due to abnormal Papanicolaou smear.
    Monsonego J; Pollini G; Evrard MJ; Sednaoui P; Monfort L; Quinzat D; Dachez R; Syrjänen K
    Int J STD AIDS; 2008 Jun; 19(6):385-92. PubMed ID: 18595876
    [TBL] [Abstract][Full Text] [Related]  

  • 70. An evaluation of human papillomavirus testing for intermediate- and high-risk types as triage before colposcopy.
    Hatch KD; Schneider A; Abdel-Nour MW
    Am J Obstet Gynecol; 1995 Apr; 172(4 Pt 1):1150-5; discussion 1155-7. PubMed ID: 7726250
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparative analysis of cervical cytology and human papillomavirus genotyping by three different methods in a routine diagnostic setting.
    Padalko E; Ali-Risasi C; Mesmaekers S; Ryckaert I; Van Renterghem L; Lambein K; Bamelis M; De Mey A; Sturtewagen Y; Vastenavond H; Broeck DV; Weyers S; Praet M
    Eur J Cancer Prev; 2015 Sep; 24(5):447-53. PubMed ID: 25370681
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Detection and typing of human papilloma virus DNAs in normal cervix, intraepithelial neoplasia and cervical cancer in Bangkok.
    Siritantikorn S; Laiwejpithaya S; Siripanyaphinyo U; Auewarakul P; Yenchitsomanus P; Thakernpol K; Wasi C
    Southeast Asian J Trop Med Public Health; 1997 Dec; 28(4):707-10. PubMed ID: 9656389
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparative analysis of a liquid-based Pap test and concurrent HPV DNA assay of residual samples. A study of 608 cases.
    Hong IS; Marshalleck J; Williams RH; Gaiter TE; Mielzynska-Lohnas I; Kim K
    Acta Cytol; 2002; 46(5):828-34. PubMed ID: 12365215
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Assessment of reflex human papillomavirus DNA testing in patients with atypical endocervical cells on cervical cytology.
    Chen L; Yang B
    Cancer; 2008 Aug; 114(4):236-41. PubMed ID: 18548530
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Significance of high-risk human papillomavirus DNA detection in women 50 years and older with squamous cell papanicolaou test abnormalities.
    Zhao C; Zhao S; Heider A; Austin RM
    Arch Pathol Lab Med; 2010 Aug; 134(8):1130-5. PubMed ID: 20670132
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Expanded cytological referral criteria for colposcopy in cervical screening: comparison with human papillomavirus testing.
    Paraskevaidis E; Malamou-Mitsi V; Koliopoulos G; Pappa L; Lolis E; Georgiou I; Agnantis NJ
    Gynecol Oncol; 2001 Aug; 82(2):355-9. PubMed ID: 11531293
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical performance of the aptima HPV assay in 4196 women with positive high-risk HPV and ASC-US cytology: A large women hospital experience.
    Wang T; Pradhan D; Zhang H; Matsko J; Zhao C
    Diagn Cytopathol; 2021 Jan; 49(1):5-10. PubMed ID: 32857920
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Managing atypical squamous cells of undetermined significance in Papanicolaou smears.
    Morin C; Bairati I; Bouchard C; Fortier M; Roy M; Moore L; Meisels A
    J Reprod Med; 2001 Sep; 46(9):799-805. PubMed ID: 11584480
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparison of two tests for detecting carcinogenic HPV in women with Papanicolaou smear reports of ASCUS and LSIL.
    Ferris DG; Wright TC; Litaker MS; Richart RM; Lorincz AT; Sun XW; Woodward L
    J Fam Pract; 1998 Feb; 46(2):136-41. PubMed ID: 9487319
    [TBL] [Abstract][Full Text] [Related]  

  • 80. High-risk cervical epithelial neoplasia grade 1 treated by loop electrosurgical excision: follow-up and value of HPV testing.
    Alonso I; Torné A; Puig-Tintoré LM; Esteve R; Quinto L; Garcia S; Campo E; Pahisa J; Ordi J
    Am J Obstet Gynecol; 2007 Oct; 197(4):359.e1-6. PubMed ID: 17714678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.